Comparative study of cryotherapy and interlesional Glucantime in the treatment of cutaneous leishmaniasis

Comparative study of cryotherapy and interlesional Glucantime in the treatment of cutaneous leishmaniasis

The World Health Organization estimates that approximately 400.000 new cases of Leishmaniasis occur worldwide each year. Cutaneous Leishmaniasis is an endemic disease in Iran. CL is caused by several species of Leishmania. Physical and Chemical Modalities have been used to treatment of cutaneous Lei...

Full description

Bibliographic Details
Main Author:	Akhyani M
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 1997-07-01
Series:	Tehran University Medical Journal
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5895.pdf&manuscript_id=5895

Similar Items

Comparison between intralesional glucantime injection and cryotherapy in papular cutaneous leishmaniasis
by: Yazdanpanah MJ, et al.
Published: (2006-10-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

Comparing the Effects of Topical Miltefosine and Glucantime in Treatment of Cutaneous Leishmaniasis
by: Ali Asilian, et al.
Published: (2014-03-01)

Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran
by: Mahmoud Mohammadzadeh, et al.
Published: (2013-04-01)

A Comparetaive Study on Glucantime and Oral Terbinafine along with Systemic Glucantime on Cutaneous Leishmaniasis
by: Saba Ebrahimian, et al.
Published: (2011-03-01)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
by: Simindokht Soleimanifard, et al.
Published: (2017-01-01)

Treatment of cutaneous leishmaniasis: cassia fistula fruit gel- intralesional glucantime Vs. placebo gel- intralesional glucantime combination
by: Jaffary F, et al.
Published: (2010-01-01)

Topical Fluconazole Combined with Local Glucantime Injection Compared with Local Glucantime Injections in Treatment of Leishmaniasis
by: Mohammad Ali Nilforooshzadeh, et al.
Published: (2011-03-01)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
by: Sohrab Iranpour, et al.
Published: (2019-03-01)

The Skin Side Effects of Topical Glucantime in Patients with Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2015-08-01)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2013-03-01)

Cutaneous Leishmaniasis – Dermoscopic Findings And Cryotherapy
by: Dobrev Hristo P., et al.
Published: (2015-03-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-05-01)

Tc1 Cells Percentage in Patients with Cutaneous Leishmaniasis before and after Treatment with Glucantime
by: M Mohajery, et al.
Published: (2007-03-01)

The Additive Effect of Topical Ciprofloxacin 2% on Intralesional Glucantime Injection in Treatment of Cutaneous Leishmaniasis
by: Mohamadjavad Yazdanpanah, et al.
Published: (2020-06-01)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
by: Moradi Shahram, et al.
Published: (2007-04-01)

Decreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
by: G Sadeghian, et al.
Published: (2011-01-01)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
by: Fariba Jaffary, et al.
Published: (2016-01-01)

PERILESIONAL INFILTRATION OF GLUCANTIME AND LIDOCAINE FOR TREATMENT OF LEISHMANIASIS
by: Reyes Alirio Torres, et al.
Published: (2000-05-01)

The Effect of Local Allergic Reaction to Intralesional Glucantime on Recovery Course of Cutaneous Leishmaniasis
by: Saman Afkhami-Ardakani, et al.
Published: (2020-04-01)

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites.
by: Ramtin Hadighi, et al.
Published: (2006-05-01)

Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis
by: Masoud Maleki, et al.
Published: (2012-01-01)

The Efficacy of Achillea Millefolium Topical Gel Along with Intralesional Injection of Glucantime in the Treatment of Acute Cutaneous Leishmaniasis
by: Fariba Jaffary, et al.
Published: (2012-03-01)

Clinical and laboratory evaluation of cured and non-cured patients with cutaneous leishmaniasis treated by Glucantime
by: F Ezatkhah, et al.
Published: (2019-01-01)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
by: Pouran Layegh, et al.
Published: (2011-01-01)

A Comparison of the Effects of Topical Injection of Glucantime Plus Glycolic Acid 70% and Salicylic Acid 20% with Topical Injection of Glucantime Alone in the Treatment of Acute Cutaneous Leishmaniasis
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2017-04-01)

Serum Monocyte Chemotactic Protein-1 and Nitric Oxide in Cutaneous Leishmaniasis Patients before and after Treatment with Glucantime
by: Faezeh Mohammadi, et al.
Published: (2012-03-01)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
by: Fariba Jaffary, et al.
Published: (2014-01-01)

Cryotherapy of cutaneous leishmaniasis caused by Leishmania major in BALB/c mice: A comparative experimental study
by: Minoo Shaddel, et al.
Published: (2018-01-01)

Treatment of Glucantim™-Resistant Cutaneous Leishmaniasis Using Combination Therapy of Allopurinol and Trichloroacetic Acid (TCA) 50%; Report of Three Cases
by: Giti Sadeghian, et al.
Published: (2017-01-01)

Interleukin-10 and Interferon-γ Levels in Patients with Cutaneous Leishmaniasis Treated with Cryotherapy
by: Farhad Handjani, et al.
Published: (2017-09-01)

The Efficacy of Intralesional Injection of Glucantime with Mesotherapy for the Treatment of Cutanuos Leishmaniasis in Comparison to Classic Method
by: Zabiholah Shahmoradi, et al.
Published: (2011-03-01)

Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy
by: Claude Pirmez, et al.
Published: (1990-06-01)

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime<sup>®</sup>) in Cutaneous Leishmaniasis
by: Aishah E. Albalawi, et al.
Published: (2021-03-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: M Mohebali, et al.
Published: (2010-09-01)

Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice
by: M.A. Nilforoushzadeh, et al.
Published: (2008-11-01)

Comparison of Quality of Life in Women Suffering from Cutaneous Leishmaniasis Treated with Topical and Systemic Glucantime along with Psychiatric Consultation Compared with the Group without Psychiatric Consultation
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2012-03-01)

Comparison between Combination Therapy of Oral Terbinafine and Cryotherapy versus Systemic Meglumine Antimoniate and Cryotherapy in Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Saeedeh Farajzadeh, et al.
Published: (2015-03-01)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Sup-plementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
by: F Zamani Sorkhroodi, et al.
Published: (2010-09-01)

Alterações renais por hipersensibilidade ao uso de antimonial pentavalente (Glucantime®) na leishmaniose tegumentar americana: relato de um caso Nephrotoxicity to Glucantime® in the treatment of Leishmaniasis
by: Luis Carlos Cucé, et al.
Published: (1990-08-01)

Cannot write session to /tmp/vufind_sessions/sess_2137njsmkbdtoq2i1i7jp8ebct